On the recording of sample times and parameter estimation from repeated measures pharmacokinetic data
Tóm tắt
Từ khóa
Tài liệu tham khảo
R. Temple. Discussion paper on the testing of drugs in the elderly.Memorandum of the Food and Drug Administration, DHHS, Washington, DC, Sept. 30, 1983.
R. Temple. The clinical investigation of drug use by the elderly: Food and Drug guidelines.Clin. Pharmacol. Ther. 42:681–685 (1987).
Guideline for the study of drugs likely to be used in the elderly. Center for Drug Evaluation and Research, Food and Drug Administration, DHHS, Washington DC, Nov. 1989.
E. I. Ette, H. Sun, and T. M. Ludden. Design of population pharmacokinetic studies.Proceedings Am. Statist. Assoc. (Biopharm. Section), 1994, pp. 487–492.
Y. Hashimoto and L. B. Sheiner. Designs for population pharmacodynamics: Value of pharmacokinetic data and population analysis.J. Pharmacokin. Biopharm. 19:333–353 (1991).
D. Z. D'Argenio and A. Schumitzky,ADAPT II User's Guide, Biomedical Simulation Resource, University of Southern California, Los Angeles, 1992.
L. Endrenyi. Design of experiments for estimating enzyme and pharmacokinetic experiments. In L. Endrenyi (ed).Kinetic Data Analysis of Enzyme and Pharmacokinetic Experiments, Plenum Press, New York, 1981, pp. 137–167.
Microft Excel (version 5.0). Microsoft Corp., 1993.
S. L. Beal and L. B. Sheiner,NONMEM Users Guide, Parts I–VI, Division of Clinical Pharmacology, University of California, San Francisco, 1979–1992.
D. A. Graves, C. S. Locke, Jr., K. T. Muir, and R. P. Miller. The influence of assay variability on pharmacokinetic parameter estimation.J. Pharmacokin. Biopharm. 17:571–592 (1989).
L. B. Sheiner and S. L. Beal. Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data.J. Pharmacokin. Biopharm. 11:303–319 (1983).
M. K. Al-Banna, A. W. Kelman, and B. Whiting. Experimental design and efficient parameter estimation in population pharmacokinetics.J. Pharmacokin. Biopharm. 18:347–360 (1990).
D. B. White, C. A. Walawander, Y. Tung, and T. H. Grasela. An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis.J. Pharmacokin. Biopharm. 19:87–112 (1991).
E. I. Ette, A. W. Kelman, C. A. Howie, and B. Whitting. Interpretation of simulation studies for efficient estimation of population pharmacokinetic parameters.Ann. Pharmacother. 27:1034–1039 (1993) and Correction,Ann. Pharmacother. 27:1548 (1993).
E. I. Ette, A. W. Kelman, C. A. Howie, and B. Whiting. Influence of inter-animal variability on the estimation of population pharmacokinetic parameters in preclinical studies.Clin. Res. Reg. Affairs 11:121–139 (1994).